Wilterding Mark 4
4 · RxSight, Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Wilterding Mark
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-28+20,441→ 20,441 total - Tax Payment
Common Stock
2026-02-28$7.61/sh−8,068$61,397→ 12,373 total - Exercise/Conversion
Restricted Stock Unit
[F1][F2]2026-02-28−20,441→ 143,087 total→ Common Stock (20,441 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award vested on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.
Signature
/s/ Jim Schindler, as Attorney-in-Fact|2026-03-03